Search

everythinglearnresearchcommunity

for

Search:↓

The treatment showed high response rates and was well-tolerated, potentially extending patient survival.

UTMD with diclofenac and Doxil® improves cancer treatment by boosting immune response and reducing tumor-supporting cells.

Disitamab vedotin and gemcitabine effectively treated bladder cancer without major side effects.

Dupilumab significantly improved a 5-year-old girl's prurigo nodularis without side effects.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

The treatment combination is effective and generally safe for lung cancer.

The document concludes that systemic therapy is becoming more important in treating head and neck cancer, with new treatments showing promise.

Cancer treatments often cause hair loss, and more research is needed to prevent and treat it.

Targeted therapies for lung cancer are effective but require careful management of side effects to benefit patients.

NF-κB signaling is crucial in many diseases and can be targeted for new treatments.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

Early recognition of skin issues in immunocompromised patients is crucial for better outcomes.

Regulatory T cells adapt to different environments to control inflammation and support tissue repair.

Bullous pemphigoid, intrahepatic cholangiocarcinoma, and alopecia areata may share immune-related causes.

Scalp cooling helps prevent hair loss during chemotherapy, and minoxidil aids regrowth.

Gemcitabine and Disitamab Vedotin effectively and safely reduced bladder cancer in a patient.

Dupilumab effectively reduces symptoms of prurigo nodularis and is safe for long-term use.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

Dupilumab effectively improves skin conditions, reduces symptoms, and enhances quality of life in certain dermatological issues.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.

Dupilumab improved severe atopic dermatitis in a patient who didn't respond to other treatments.

A cancer patient's hair became permanently curly after treatment with nivolumab.

A medication for skin rash also unexpectedly treated hair loss in a patient.

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

Dupilumab effectively treats various inflammatory skin diseases beyond its initial use for atopic dermatitis.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.